Summary: The occurrence and characteristics of macromolecular components of normal human myometrium and leiomyoma which bind [ Sedimentation patterns as well as elution profiles from agarose gel revealed a striking similarity between biochemical properties of the progesterone receptors from normal myometrium and leiomyomas of the same organ.
Introduction
The uterus, the target organ for ovarial steroid hormones, has a property characteristic of target organs, i. e., the accumulation of steroid hormones against a concentration gradient. Specific high affinity cytoplasmic receptor proteins for steroid hormones, whose existence was first demonstrated by Jensen et al. (1) , are responsible for this phenomenon. These receptor proteins, of which there is one specific type for each steroid hormone, are essential components in the chain of action of steroid hormones in the target cell. After the steroid hormone has entered the target cell from the blood, it binds to the appropriate receptor molecule to form a hormone-receptor complex, which translocates to the nucleus after activation. In the nucleus, the site of the genetic apparatus, the hormone receptor complex binds to the chromatin. This interaction leads to activation at the transcription level, followed by an increase in protein synthesis. Although a large number of the individual processes in this sequence are still unclear, it is probable that some of them are the cause of growth and/or differentiation of the uterus under the influence of steroid hormones.
Studies on the specific cytoplasmic receptor proteins binding estradiol and progesterone in human myometrium and endometrium have shown that the concentrations of these steroid hormone receptors change during the course of the menstrual cycle (2) (3) (4) (5) (6) (7) (8) (9) (10) . Practical clinical experience has also shown that the growth of leiomyomas, benign neoplasias of the muscle layer of the uterus, can be affected by changes in the hormone status during the menstrual cycle and during pregnancy. The question is, why leiomyomas escape the growth inhibition exerted by the surrounding hormonal milieu, and develop, so to speak, their own growth control. Comparison of the steroid hormone receptors in normal myometrium and leiomyomas from the same uterus may help to answer this question. In this connection, not only the quantitative analysis of the estrogen and progesterone binding receptor molecules is of interest, but also the biochemical characterization of the two receptors in normal and neoplastic tissues.
Materials and Methods

Steroids
(1, 2-3 H)Progesterone (spec, activity 1.96 PBq/mol = 53 Ci/mmol) and [6, H]estradiol-170 (spec, activity 1.48 PBq/mol = 40 Ci/mmol) were purchased from the'Radioĉ hemical Centre (Amersham, England). All radioactive steroids were purified by thin-layer chromatography before use. Unlabelled steroids were a gift from Schering AG (Berlin, Germany).
Tissue
Uterine tissue was obtained from normal fertile or postmenopausal women, who underwent hysterectomy because of myomata uteri. Immediately after hysterectomy the uterus was placed on ice, myometrium and endometrium were separated from one another, and portions of each tissue were removed for microscopic study. The interval between hysterectomy and the start of the cytosol preparation was usually less than 30 min. The menstrual age of the rnypmetrium was based on a 28-day cycle by rating histological sections of normal endometrium according to the scheme ofNoyes et al. (11) . Preparation of subcellular fractions Tissue was processed at 4 °C. Fresh tissue samples were weighed, washed in ice cold buffer (containing 50 mmol/1 tris/HCl, pH 7.0,1.25 mmol/1 EDTA, 12 mmol/1 mercaptoethanöl, 200 ml/1 glycerol), and gently homogenized in a 4rfold volume (w/v) of the same buffer. Homogenization was performed with an Ultra Turrax for 5 pulses (each 20 s). This homogenization was followed by homogenization with a glass homogenizer fitted with a teflon pestle (5 strokes). The homogeriate was filtered through 4 layers of cheese-cloth. To obtain the nuclear fraction, the filtrate was centrifuged at 850 # for, 15 min, and the nuclear pellet washed twice in buffer A (10 mmol/1 tris/ HC1, 0.1 mol/1 NaCl, 5 mmol/1 KC1, 3 mmol/1 MgCl 2 , 1.5 mmol/1 CaCl2> 200 ml/1 glycerol, 7.0) by dispersing with a Dounce homogenizer and centrifuged twice at 85 0# for 15 min. The nuclear pellet was resuspended in buffer A containing 2.4 mol/1 sucrose, layered on a cushion of 2.4 mol/1 sucrose buffer A and centrifuged at 60,000 £ for 60 mm at 4 °C. The resulting pellet was designated the "purified nuclei". The 850 £ supernatant was centrifuged for 30 min at 105,000£ to obtain a clear cytosol containing only the fully soluble proteins. Serum was obtained by low speed centrifugation of the blood samples of pregnant women and was stored at -70 °C.
Sucrose density gradient centrifugation Samples (4.6 mg protein per ml cytosol) for density gradient centrifugation (5 to 20% linear sucrose gradient in tris-EDTAmercaptpethanpl-glycerol buffer) with or without KC1 were reacted for 10 h at 4 °C with 2 nmol/1 [ 3 H]progesterone without any competitor. In a second set of tubes a 100-fold excess of unlabelled progesterone or cortisol was added to the radioactive steroid. Incubations were performed for 16 h at 4 °C. Thereafter 0.2 ml aliquots of the samples were centrifuged for 16 h at 234,000£ (rotor SW 50.1, Beckman Instruments). Bovine serum albumin was run simultaneously as the reference protein in the estimation of sedimentation coefficients. Fractions were collected from the top of the gradient by means of the Isco-piercing unit and drop counter. Radioactivity was determined in 0.1 ml aliquots of undiluted fractions. Quenching of radioactivity by sucrose did not vary significantly. .
Agarose gel filtration
Bio Gel A-0.5 m (200-400 mesh, Bio-Rad Laboratories, Mün-· chen, Germany) was packed in columns (1.5 cm i. d.) to a height of 100 cm and washed with the elating buffer solution (tris-EDTA-mercaptoethanol-glycerol buffer). The gel exclusion characteristics of the column were measured with standard proteins. Samples (15.8 mg protein per nil eytosol) were applied to the column in 2 ml volumes together with Chlorophenol Red and Dextran Blue to serve as indicators. Dextran Blue was eiuted in the void volume while the red dye was eluted with free [
3 H]steroid. Elution was carried out at a flow rate of 8.5 ml/h. Then 1.5 ml fractions were collected and aliquots were counted for radioactivity.
M e a su re m en t of progesterone binding sites in myometrial cytosol by equilibrium dialysis Cytosols were diluted with tris-EDTA-mercaptoethanotglycerol buffer to a final protein concentration of 1 g/1. The equilibrium dialysis was performed according to the method described in detail by Davies (12) . A dialysis bag containing 1 ml of cytosol was introduced into 5 ml of homogenization buffer containing increasing concentrations of [excess over the highest [ 3 H]steroid level. Cortisol was added to eliminate binding by contaminating serum corticosteroidbinding globulin. The diluted cytosols were incubated at 4 °C for 16 h with shaking. The deviation of the number of binding sites as well as the association constant (K a ) from the multiple dialysis were based on linearization of the data as described by Scatchard (13) .
Determination of estradiol binding
The diluted cytosols (1 g/1) were incubated at 4 °C for 16 h with [ 3 Hjestradiol over a 30-fold concentration range (0.5 to 15 nmol/1). Tubes containing 1 μηιοΐ/l unlabelled estradiol were used to correct for nonspecific binding. Binding was then measured using the charcoal adsorption technique: The pellet obtained from the centrifugation (2 min at 10,000 g) of 0.4 ml of 2.5 g/1 charcoal plus 0.25 g/1 dextran in 50 mmol/1 tris/HCl buffer (pH 7.0) was mixed with the cytosol; after 20 min at 4 °C, the dextran-coated charcoal was removed by centrif ugation for 10 min at 10,000 £. The bound radioactivity of the samples was counted for radioactivity. The association constant (K a ) and the concentration of binding sites were calculated according to Scatchard. 3 H]progesterone from cytosol to nucleus, tissue slices from early proliferative and early secretory myometrium as well as leiomyoma were incubated in &agle*s medium for 10 min at 4 °C, then rinsed and transferred to fresh Eagle*s medium and incubated for various periods as indicated at 37 °C. After incubation the tissue was homogenized and fractionated as described under "Preparation of subcellular fractions'*. The nuclear pellet was purified by passing through 2.4 mol/1 sucrose. The cytoplasmic fraction and purified nuclei were then extracted with chloroform/ethanpl (3 ml + 1 ml). The ordinate is expressed as counts per min per 1.0 g of tissue.
Protein assay Protein was measured using the method ofLowry et al. (14) with bovine serum albumin as standard.
Results
The kinetics of [
3 H]progesterone binding to specific receptor molecules of human 'normal myometrium and leiomyoma cytosol is demonstrated in figure 1 . It is evident that after 10 h at 4 °C, the amount of bound radioactivity remained constant up to 100 h of incubation. In all further experiments an incubation time of at least 16 h was employed. respect to the phase of the menstrual cycle. In general, the proliferative specimens contain significantly higher concentrations of progesterone receptor than the secretory samples. During the proliferative phase the progesterone receptor level increased toward the 14th day of the menstrual cycle, reached its highest value around the time of ovulation and declined sharply during the secretory phase.
In figure 6 the specific progesterone binding capacity of cytosol obtained from normal myometrium is plotted against the age of the women. The highest binding site concentrations were found in tissue samples of normal fertile women; in postmenopausal uteri the specific binding capacity was low.
The cytosols of 16 leiomyomas were examined for the presence of progesterone-specific binding ( fig. 7) . In all tumor samples progesterone binding activity was detectable, but the leiomyomas had significantly lower binding activity than did normal human myometrium obtained from normal fertile or postmenopausal women. Concentration of the specific estradiol binding sites during the menstrual cycle and in leiomyoma
The level of unoccupied specific cytoplasmic estradiol receptor reached a maximum early in the first half of the cycle and steadily declined thereafter, to its lowest value late in the secretory phase ( fig. 8 ).
The influence of the age of the patient on the cytoplasmic estradiol receptor content in normal myometrium is shown in figure 9 . Premenopausal .patients were those regularly menstruating; postmenopausal ones had their last menstrual period at least 1 year before. With regard to the mean receptor concentrations, the estradiol receptor levels were significantly lower in pre-than in post-menopausal women, whereas the reverse was true for the progesterone receptor binding activity (see fig. 6 ). The cytosols of 32 leiomyomas were examined for the presence of estradiol-specific Tissue slices from early proliferative (3 cases) and early secretory (5 cases) myometrium and from leiomyoma (4 cases) were incubated in Eagle's medium for 10 min at 4° C, then rinsed and transferred to fresh Eagle's medium and incubated for various periods as indicated. After incubation the tissue was homogenized and fractionated as described under "Materials and Methods". Cytoplasmic fraction (--) and purified nuclei (^ ^= -) were then extracted with chloroform/ethanol (volumes, 3 + 1).
Discussion
The results of the present studies demonstrate the existence of high-affinity, low-capacity binding components for estradiol and progesterone in the cytoplasmic fractions of normal myometrium and leiomyomas. These specific hormone-binding protein components have the properties of receptors (sedimentation in density gradients, competitive binding studies, elution profile after agarose gel filtration, high affinity binding). These observations confirm the studies of others (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) .
Comparison of the biochemical properties of the cytoplasmic progesterone binding receptor molecules from normal and neoplastic myometrium (for the estradiol receptor, see Follow et al., 1. c . (28)) shows that there are no differences between the receptors from these two tissues with respect to their affinity for progesterone, their sedimentation properties in sucrose density gradient, or their elution profile after agarose gel filtration. This indicates that the neoplastic tissue contains a progesterone receptor which is similar or identical to the one found in normal human myometrium. Quantitative differences between the two types of tissue were observed with respect to binding of ovarial steroid hormones. In normal human myometrium, the concentration of progesterone binding receptor sites varies during the menstrual cycle. Cycle-dependent variations in the concentration of the receptor proteins are particularly interesting, because the hormone receptors directly influence the control of the genetic apparatus. The highest concentrations of progesterone receptors were observed in mid-cycle. This is an agreement with the results oflllingworth et al. (26) , and Kontula (21).
Examination of the estradiol receptors in the myometrium during the fertility period showed that the highest cytoplasmic concentrations occur during the proliferative phase. There may be two causes for the changes in steroid hormone receptor concentration in the myometrium during the menstrual cycle:
1. Progesterone, the predominant steroid hormone during the second half of the cycle, acts as a negative effector both for its own receptor and for the estradiol receptor, reducing the concentration of both during the second half of the cycle, and 2. due to the inductive effect of the progesterone receptor mechanism, there is a large increase in 17/Jhydroxysteroid dehydrogenase activity, which reduces the intracellular estradiol concentration.
The result is that the estradiol receptor mechanism, which is responsible for both its own induction and that of the progesterone receptor, is blocked (10, 29, 30) .
The results of the comparative analysis of steroid hormone receptor levels in normal myometrium and leiomyomas from the same uteri are rather interesting. The present study shows that leiomyomas are characterized by low cytoplasmic concentrations of progesterone receptors, but high estradiol receptor levels, comparable to those in normal myometrium. This observation is supported by the comparison of the sedimentation patterns of nucleus-bound steroid hormone receptors from normal myometrium in the middle proliferative and early secretory phases and from leiomyoma, and by kinetics of steroid hormone transfer from the cytoplasm to the nucleus under equilibrium conditions.
Our results on the estradiol receptor are in agreement with the findings of Farber et al. (31) , Puukka et al. (33) and with the most recent data of Daxenbichler et al. (32) , who were also unable to find any significant differences in the estradiol receptor complement of leiomyoma and normal myometrium. However, there is a discrepancy with respect to the progesterone receptor content: Daxenbichler et al. found no significant differences between the two types of tissue, although they report a tendency toward lower progesterone receptor concentrations in the leiomyomas of patients older than 45 years than iri normal myometrium from patients of the same age. (29, 30) and our group (10) on human endometrium have shown, is subject to the inductive effect of the progesterone receptor mechanism. One can only speculate on the cause and pathophysiological significance of the differences in progesterone receptor contents of normal myometrium and leiomyoma: Since, as animal experiments have shown, the progesterone receptor is induced via the estradiol receptor mechanism, and thus represents an end product of the chain of estradiol action, it can be inferred that an alteration at one of the steps sur> sequent to the translpeation of the estradiol receptor (transcription, processing, translation) leads to the "progesterone receptor defect". Since the progesterone receptor mediates the physiological braking action of progesterone on the biologically active estradipl, which is responsible for proliferation and mitosis activity, the possibility cannot be excluded that the continuous and uninhibited estrogen stimulation is a cofactor supporting the neoplastic transition. It is too early to speak of an etiological factor, however^ since correlations do not prove etiology.
